Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia

Objective: To demonstrate that glycemia and insulin resistance are controlled by a mechanism involving the adaptive immune system and gut microbiota crosstalk. Methods: We triggered the immune system with microbial extracts specifically from the intestinal ileum contents of HFD-diabetic mice by the...

Full description

Bibliographic Details
Published in:Molecular Metabolism
Main Authors: Céline Pomié, Vincent Blasco-Baque, Pascale Klopp, Simon Nicolas, Aurélie Waget, Pascale Loubières, Vincent Azalbert, Anthony Puel, Frédéric Lopez, Cédric Dray, Philippe Valet, Benjamin Lelouvier, Florence Servant, Michael Courtney, Jacques Amar, Rémy Burcelin, Lucile Garidou
Format: Article
Language:English
Published: Elsevier 2016-06-01
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877816300047
_version_ 1851901281494368256
author Céline Pomié
Vincent Blasco-Baque
Pascale Klopp
Simon Nicolas
Aurélie Waget
Pascale Loubières
Vincent Azalbert
Anthony Puel
Frédéric Lopez
Cédric Dray
Philippe Valet
Benjamin Lelouvier
Florence Servant
Michael Courtney
Jacques Amar
Rémy Burcelin
Lucile Garidou
author_facet Céline Pomié
Vincent Blasco-Baque
Pascale Klopp
Simon Nicolas
Aurélie Waget
Pascale Loubières
Vincent Azalbert
Anthony Puel
Frédéric Lopez
Cédric Dray
Philippe Valet
Benjamin Lelouvier
Florence Servant
Michael Courtney
Jacques Amar
Rémy Burcelin
Lucile Garidou
author_sort Céline Pomié
collection DOAJ
container_title Molecular Metabolism
description Objective: To demonstrate that glycemia and insulin resistance are controlled by a mechanism involving the adaptive immune system and gut microbiota crosstalk. Methods: We triggered the immune system with microbial extracts specifically from the intestinal ileum contents of HFD-diabetic mice by the process of immunization. 35 days later, immunized mice were fed a HFD for up to two months in order to challenge the development of metabolic features. The immune responses were quantified. Eventually, adoptive transfer of immune cells from the microbiota-immunized mice to naïve mice was performed to demonstrate the causality of the microbiota-stimulated adaptive immune system on the development of metabolic disease. The gut microbiota of the immunized HFD-fed mice was characterized in order to demonstrate whether the manipulation of the microbiota to immune system interaction reverses the causal deleterious effect of gut microbiota dysbiosis on metabolic disease. Results: Subcutaneous injection (immunization procedure) of ileum microbial extracts prevented hyperglycemia and insulin resistance in a dose-dependent manner in response to a HFD. The immunization enhanced the proliferation of CD4 and CD8 T cells in lymphoid organs, also increased cytokine production and antibody secretion. As a mechanism explaining the metabolic improvement, the immunization procedure reversed gut microbiota dysbiosis. Finally, adoptive transfer of immune cells from immunized mice improved metabolic features in response to HFD. Conclusions: Glycemia and insulin sensitivity can be regulated by triggering the adaptive immunity to microbiota interaction. This reduces the gut microbiota dysbiosis induced by a fat-enriched diet. Keywords: Gut microbiota and metabolic diseases, Immunity, Insulin resistance
format Article
id doaj-art-e5665fbf701e453c8a5af6d69022b99a
institution Directory of Open Access Journals
issn 2212-8778
language English
publishDate 2016-06-01
publisher Elsevier
record_format Article
spelling doaj-art-e5665fbf701e453c8a5af6d69022b99a2025-08-19T22:05:44ZengElsevierMolecular Metabolism2212-87782016-06-015639240310.1016/j.molmet.2016.03.004Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemiaCéline Pomié0Vincent Blasco-Baque1Pascale Klopp2Simon Nicolas3Aurélie Waget4Pascale Loubières5Vincent Azalbert6Anthony Puel7Frédéric Lopez8Cédric Dray9Philippe Valet10Benjamin Lelouvier11Florence Servant12Michael Courtney13Jacques Amar14Rémy Burcelin15Lucile Garidou16Institut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: « Intestinal Risk Factors, Diabetes, Dyslipidemia », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: « Intestinal Risk Factors, Diabetes, Dyslipidemia », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: « Intestinal Risk Factors, Diabetes, Dyslipidemia », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: « Intestinal Risk Factors, Diabetes, Dyslipidemia », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: « Intestinal Risk Factors, Diabetes, Dyslipidemia », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: « Intestinal Risk Factors, Diabetes, Dyslipidemia », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: « Intestinal Risk Factors, Diabetes, Dyslipidemia », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: « Intestinal Risk Factors, Diabetes, Dyslipidemia », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, FranceGroupe Protéomique Centre Recherche Cancer Toulouse, Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1037, 2 avenue Hubert Curien, CS 53717, 31037 Toulouse Cedex 1, FranceUniversité Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 3: « Adipokines, obesity and associated Pathologies », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, FranceUniversité Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 3: « Adipokines, obesity and associated Pathologies », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, FranceVAIOMER SAS, 516 Rue Pierre et Marie Curie, 31670 Labège, FranceVAIOMER SAS, 516 Rue Pierre et Marie Curie, 31670 Labège, FranceVAIOMER SAS, 516 Rue Pierre et Marie Curie, 31670 Labège, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: « Intestinal Risk Factors, Diabetes, Dyslipidemia », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: « Intestinal Risk Factors, Diabetes, Dyslipidemia », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, France; Corresponding author. INSERM UMR1048-I2MC, Team 2 “Intestinal Risk Factors, Diabetes and Dyslipidemia”, 1 avenue Jean Poulhès, BP84225, F-31432 Toulouse Cedex 4, France. Tel. +33 561 325 614; fax: +33 5 31 22 41 36.Institut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: « Intestinal Risk Factors, Diabetes, Dyslipidemia », 1 avenue Jean Poulhès, BP 84225, F-31432 Toulouse Cedex 4, France; Corresponding author. INSERM UMR1048-I2MC, Team 2 “Intestinal Risk Factors, Diabetes and Dyslipidemia”, 1 avenue Jean Poulhès, BP84225, F-31432 Toulouse Cedex 4, France. Tel. +33 561 325 614; fax: +33 5 31 22 41 36.Objective: To demonstrate that glycemia and insulin resistance are controlled by a mechanism involving the adaptive immune system and gut microbiota crosstalk. Methods: We triggered the immune system with microbial extracts specifically from the intestinal ileum contents of HFD-diabetic mice by the process of immunization. 35 days later, immunized mice were fed a HFD for up to two months in order to challenge the development of metabolic features. The immune responses were quantified. Eventually, adoptive transfer of immune cells from the microbiota-immunized mice to naïve mice was performed to demonstrate the causality of the microbiota-stimulated adaptive immune system on the development of metabolic disease. The gut microbiota of the immunized HFD-fed mice was characterized in order to demonstrate whether the manipulation of the microbiota to immune system interaction reverses the causal deleterious effect of gut microbiota dysbiosis on metabolic disease. Results: Subcutaneous injection (immunization procedure) of ileum microbial extracts prevented hyperglycemia and insulin resistance in a dose-dependent manner in response to a HFD. The immunization enhanced the proliferation of CD4 and CD8 T cells in lymphoid organs, also increased cytokine production and antibody secretion. As a mechanism explaining the metabolic improvement, the immunization procedure reversed gut microbiota dysbiosis. Finally, adoptive transfer of immune cells from immunized mice improved metabolic features in response to HFD. Conclusions: Glycemia and insulin sensitivity can be regulated by triggering the adaptive immunity to microbiota interaction. This reduces the gut microbiota dysbiosis induced by a fat-enriched diet. Keywords: Gut microbiota and metabolic diseases, Immunity, Insulin resistancehttp://www.sciencedirect.com/science/article/pii/S2212877816300047
spellingShingle Céline Pomié
Vincent Blasco-Baque
Pascale Klopp
Simon Nicolas
Aurélie Waget
Pascale Loubières
Vincent Azalbert
Anthony Puel
Frédéric Lopez
Cédric Dray
Philippe Valet
Benjamin Lelouvier
Florence Servant
Michael Courtney
Jacques Amar
Rémy Burcelin
Lucile Garidou
Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
title Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
title_full Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
title_fullStr Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
title_full_unstemmed Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
title_short Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
title_sort triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
url http://www.sciencedirect.com/science/article/pii/S2212877816300047
work_keys_str_mv AT celinepomie triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT vincentblascobaque triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT pascaleklopp triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT simonnicolas triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT aureliewaget triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT pascaleloubieres triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT vincentazalbert triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT anthonypuel triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT fredericlopez triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT cedricdray triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT philippevalet triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT benjaminlelouvier triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT florenceservant triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT michaelcourtney triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT jacquesamar triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT remyburcelin triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia
AT lucilegaridou triggeringtheadaptiveimmunesystemwithcommensalgutbacteriaprotectsagainstinsulinresistanceanddysglycemia